PharVision Advisers’s iRobot IRBT Stock Holding History

PharVision Advisers’s Portfolio IRBT Stock Details IRBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-52,272	Closed	-$405K	–	393
2024 Q4	$405K	Buy	+52,272	New	+$419K	0.34%	74

Other funds holding IRBT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

PharVision Advisers's IRBT Position: Q1 2025 in Review

PharVision Advisers sold out of iRobot (IRBT) in Q1 2025, closing a stake of 52,272 shares — an estimated $405K sold.

PharVision Advisers first reported a position in IRBT in Q4 2024 and held it in 1 quarter. The position peaked at $405K in Q4 2024. 150 funds tracked by Wall St. Rank hold IRBT as of Q1 2025.

PharVision Advisers reported no remaining iRobot position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 52,272 iRobot shares in Q1 2025, an estimated $405K.
PharVision Advisers first reported a position in iRobot in Q4 2024 and held it in 1 quarter.
PharVision Advisers's iRobot position peaked at $405K in Q4 2024.
150 funds tracked by Wall St. Rank held iRobot as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.